Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunil HealthcareBOM:537253 +5.72%52 Days Inventory is 238.84 as of Mar. 2026, which is 88% above its 10-year median of 126.72. GuruFocus rates BOM:537253 with a GF Score™ of 52/100 and a GF Value™ of ₹70.85 (Fairly Valued). The stock has 7 warning signs investors should review. Among 921 Drug Manufacturers companies, Sunil Healthcare ranks worse than 65.15% on this metric.
The historical rank and industry rank for Sunil Healthcare's Days Inventory or its related term are showing as below:
BOM:537253'
s Days Inventory Range Over the Past 10 Years
Min: 82.72 Med: 126.72 Max: 238.95
Current: 203.34
During the past 13 years, Sunil Healthcare's highest Days Inventory was 238.95. The lowest was 82.72. And the median was 126.72.
BOM:537253's Days Inventory is ranked worse than 65.15% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs BOM:537253: 203.34
Sunil Healthcare's Days Inventory
increased
from Mar. 2025 (176.52) to Mar. 2026 (238.84).
It might indicate that Sunil Healthcare's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sunil Healthcare's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.38.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sunil Healthcare's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.95.
Sunil Healthcare (BOM:537253) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sunil Healthcare's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sunil Healthcare's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sunil Healthcare Days Inventory Related Terms
Sunil Healthcare Days Inventory Historical Data
* Premium members only.
The historical data trend for Sunil Healthcare's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:537253 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sunil Healthcare's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunil Healthcare Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sunil Healthcare's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sunil Healthcare's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunil Healthcare (BOM:537253) has a Days Inventory of 238.84 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sunil Healthcare and its competitors. This is 88% above median its historical median of 126.72. Over the past decade, Sunil Healthcare's Days Inventory has ranged from 82.72 to 238.95. According to the industry distribution chart, Sunil Healthcare ranks #600 out of 921 companies in the Drug Manufacturers industry, placing it in the top 65.1%.
Is Sunil Healthcare's Days Inventory too high?
Sunil Healthcare's current Days Inventory of 238.84 is 88% above median its 10-year median of 126.72. Over the past 10 years, this metric has ranged from a low of 82.72 to a high of 238.95. The Drug Manufacturers industry median Days Inventory is 164.48. Sunil Healthcare's value of 238.84 is 45.2% above this industry median. Based on the distribution chart, Sunil Healthcare ranks #600 out of 921 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sunil Healthcare has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sunil Healthcare's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sunil Healthcare ranks #600 out of 921 companies for Days Inventory. This places Sunil Healthcare in the lower half of its industry. The industry median Days Inventory is 164.48. Sunil Healthcare's value of 238.84 is 45.2% above this benchmark. Historically, Sunil Healthcare's own Days Inventory has ranged from 82.72 to 238.95 over the past decade. While the company's 10-year median is 126.72 vs. the industry median of 164.48, Sunil Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunil Healthcare's current Days Inventory of 238.84 is 45.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sunil Healthcare and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunil Healthcare's current Days Inventory is 238.84, which is 88% above median its own 10-year median of 126.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunil Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sunil Healthcare (BOM:537253) is currently considered Fairly Valued. The stock's GF Value™ is ₹70.85, compared to a current price of ₹71.15 — trading 0.4% above its estimated fair value. The current Days Inventory is 238.84, which is 88% above median its 10-year median of 126.72 and 45.2% above the Drug Manufacturers industry median of 164.48. Sunil Healthcare's overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sunil Healthcare (BOM:537253), the current Days Inventory is 238.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunil Healthcare (BOM:537253) Overvalued in 2026?
Based on GuruFocus' analysis, Sunil Healthcare stock appears to be overvalued.
The current stock price of ₹71.15 is trading 0.4% above its estimated GF Value™ of ₹70.85.
GuruFocus considers Sunil Healthcare to be Fairly Valued.
Key valuation signals for BOM:537253:
Days Inventory: 238.84 (88% above median its 10-year median of 126.72)
GF Value™: ₹70.85 vs. price of ₹71.15 (0.4% above fair value)
Industry Position: 45.2% above the Drug Manufacturers median (#600 of 921)
No single metric tells the full story. See the BOM:537253 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunil Healthcare Ltd manufactures hard gelatin capsule shells that are used by pharmaceutical and food supplement companies. It operates in a single segment, that is, Empty Capsules. The company manufactures nine different sizes of capsules. Its products include BSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, and Preservative Free Capsules. The company generates the majority of its revenue from India.
52GF Score
Get the complete analysis for BOM:537253
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:537253 has been successfully added to your 
